Can be marine bioactive peptides (MBAs) lead the future of foodomics for human health?
- 10 April 2021
- journal article
- other
- Published by Taylor & Francis in Critical Reviews in Food Science and Nutrition
- Vol. 62 (25) , 7072-7116
Abstract
Marine organisms are considered a cache of biologically active metabolites with pharmaceutical, functional, and nutraceutical properties. Among these, marine bioactive peptides (MBAs) present in diverse marine species (fish, sponges, cyanobacteria, fungi, ascidians, seaweeds, & mollusks) have acquired attention owing to their broad-spectrum health-promoting benefits. Nowadays, scientists are keener exploring marine bioactive peptides precisely due to their unique structural and biological properties. These MBAs have reported ameliorating potential against different diseases like hypertension, diabetes, obesity, HIV, cancer, oxidation, and inflammation. Furthermore, MBAs isolated from various marine organisms may also have a beneficial role in the cosmetic, nutraceutical, and food industries. Few marine peptides and their derivative are approved for commercial use, while many MBAs are in various pre-clinical and clinical trials. This review mainly focuses on the diversity of marine bioactive peptides in marine organisms and their production procedures, such as chemical and enzymatic hydrolysis. Moreover, MBAs' therapeutic and biological potential has also been critically discussed herein, along with their status in drug discovery, pre-clinical and clinical trials.Keywords
This publication has 231 references indexed in Scilit:
- Predictive Factors of Sensitivity to Elisidepsin, a Novel Kahalalide F-Derived Marine CompoundMarine Drugs, 2013
- Nobilamides A–H, Long-Acting Transient Receptor Potential Vanilloid-1 (TRPV1) Antagonists from Mollusk-Associated BacteriaJournal of Medicinal Chemistry, 2011
- Azonazine, a Novel Dipeptide from a Hawaiian Marine Sediment-Derived Fungus, Aspergillus insulicolaOrganic Letters, 2010
- Mechanistic Studies of Sansalvamide A-Amide: An Allosteric Modulator of Hsp90ACS Medicinal Chemistry Letters, 2010
- Dragonamide E, a Modified Linear Lipopeptide from Lyngbya majuscula with Antileishmanial ActivityJournal of Natural Products, 2009
- Molecular pharmacodynamics of PM02734 (elisidepsin) as single agent and in combination with erlotinib; synergistic activity in human non-small cell lung cancer cell lines and xenograft modelsEuropean Journal of Cancer, 2009
- Celebesides A−C and Theopapuamides B−D, Depsipeptides from an Indonesian Sponge That Inhibit HIV-1 EntryThe Journal of Organic Chemistry, 2008
- Mollamides B and C, Cyclic Hexapeptides from the Indonesian Tunicate Didemnum molleJournal of Natural Products, 2008
- Coibamide A, a Potent Antiproliferative Cyclic Depsipeptide from the Panamanian Marine Cyanobacterium Leptolyngbya sp.Journal of the American Chemical Society, 2008
- A Chemical Study of Cyclic Depsipeptides Produced by a Sponge-Derived FungusJournal of Natural Products, 2006